Cas:7598-61-0 diethyl 2,2-diethoxyethylphosphonate manufacturer & supplier

We serve Chemical Name:diethyl 2,2-diethoxyethylphosphonate CAS:7598-61-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

diethyl 2,2-diethoxyethylphosphonate

Chemical Name:diethyl 2,2-diethoxyethylphosphonate
CAS.NO:7598-61-0
Synonyms:EINECS 231-504-0;2-diethoxyphosphoryl-1,1-diethoxyethane;MFCD00009236
Molecular Formula:C10H23O5P
Molecular Weight:254.26000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:146-149 °C14 mm Hg(lit.)
Density:1.052 g/mL at 25 °C(lit.)
Index of Refraction:n20/D 1.430(lit.)
PSA:63.80000
Exact Mass:254.12800
LogP:2.65160

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like EINECS 231-504-0 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00009236 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-diethoxyphosphoryl-1,1-diethoxyethane Use and application,2-diethoxyphosphoryl-1,1-diethoxyethane technical grade,usp/ep/jp grade.


Related News: For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains. 2-(tert-butylthio)-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethyl 2-chloroacetate manufacturers A thorough safety and risk analysis procedure should be administered at an appropriate time with documentation that adheres to the rules and regulations set forth by the regulatory authorities. methyl (2S)-2-[(2-benzoylphenyl)amino]-3-(4-{2-[2-(3-{3-[(tert-butoxycarbonyl)amino]-1-propynyl}phenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy}phenyl)propanoate suppliers The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing. 3-(2,6-difluorophenyl)-5-(1-nitropropyl)-6-(4′-(trifluoromethoxy)-[1,1′-biphenyl]-4-yl)-2,5-dihydro-1,2,4-triazine vendor & factory For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains.,“The Delta variant is clearly circulating, and it’s more contagious, and it seems to be causing more disease,” said ACIP member Katherine Poehling, M.D., an epidemiologist at Wake Forest School of Medicine.